Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Hall

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
Antiviral Therapy|April 30, 2015
Baseline prevalence and emergence of protease inhibitor resistance mutations following treatment in chronic HCV genotype-1-infected individualsLinh Thuy Nguyen, Emma Gray, Jonathan Dean, et al.
Plos One|June 3, 2017
Assessment of treatment response during chemoradiation therapy for pancreatic cancer based on quantitative radiomic analysis of daily CTs: An exploratory studyXiaojian Chen, Kiyoko Oshima, Diane Schott, et al.
Critical Reviews in Oncology/Hematology|February 18, 2019
Corrigendum to "Imaging predictors of treatment outcomes in rectal cancer: An overview" [Crit. Rev. Oncol./Hematol. 129, (September) (2018), 153-162]Lakshmi ShreeMahadevan, James Zhong, BhanuPrasad Venkatesulu, et al.
Circulation Research|November 16, 2002
HuEP5C7 as a humanized monoclonal anti-E/P-selectin neurovascular protective strategy in a blinded placebo-controlled trial of nonhuman primate strokeJ Mocco, Tanvir Choudhri, Judy Huang, et al.
Practical Radiation Oncology|June 18, 2022
ECOG-ACRIN Guideline for Contouring and Treatment of Early Stage Anal Cancer Using IMRT/IGRTNicholas Damico, Joshua Meyer, Prajnan Das, et al.
Haematologica|February 11, 2021
Loss of interleukin-10 activates innate immunity to eradicate adult T-cell leukemia-initiating cellsHiba El Hajj, Rita Hleihel, Marwan El Sabban, et al.
Surgery|January 15, 2018
Locally advanced pancreas cancer: Staging and goals of therapyNikolaos A Chatzizacharias, Susan Tsai, Michael Griffin, et al.
Frontiers in Medicine|May 30, 2023
Region-specific deep learning models for accurate segmentation of rectal structures on post-chemoradiation T2w MRI: a multi-institutional, multi-reader studyThomas DeSilvio, Jacob T Antunes, Kaustav Bera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Absence of adverse effects in cynomolgus macaques treated with CNTO 95, a fully human anti-alphav integrin monoclonal antibody, despite widespread tissue bindingPauline L Martin, Qun Jiao, Joel Cornacoff, et al.
The Journal of Experimental Medicine|December 8, 2010
Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemiaHiba El Hajj, Marwan El-Sabban, Hideki Hasegawa, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
Antiviral Therapy|April 30, 2015
Baseline prevalence and emergence of protease inhibitor resistance mutations following treatment in chronic HCV genotype-1-infected individualsLinh Thuy Nguyen, Emma Gray, Jonathan Dean, et al.
Plos One|June 3, 2017
Assessment of treatment response during chemoradiation therapy for pancreatic cancer based on quantitative radiomic analysis of daily CTs: An exploratory studyXiaojian Chen, Kiyoko Oshima, Diane Schott, et al.
Critical Reviews in Oncology/Hematology|February 18, 2019
Corrigendum to "Imaging predictors of treatment outcomes in rectal cancer: An overview" [Crit. Rev. Oncol./Hematol. 129, (September) (2018), 153-162]Lakshmi ShreeMahadevan, James Zhong, BhanuPrasad Venkatesulu, et al.
Circulation Research|November 16, 2002
HuEP5C7 as a humanized monoclonal anti-E/P-selectin neurovascular protective strategy in a blinded placebo-controlled trial of nonhuman primate strokeJ Mocco, Tanvir Choudhri, Judy Huang, et al.
Practical Radiation Oncology|June 18, 2022
ECOG-ACRIN Guideline for Contouring and Treatment of Early Stage Anal Cancer Using IMRT/IGRTNicholas Damico, Joshua Meyer, Prajnan Das, et al.
Haematologica|February 11, 2021
Loss of interleukin-10 activates innate immunity to eradicate adult T-cell leukemia-initiating cellsHiba El Hajj, Rita Hleihel, Marwan El Sabban, et al.
Surgery|January 15, 2018
Locally advanced pancreas cancer: Staging and goals of therapyNikolaos A Chatzizacharias, Susan Tsai, Michael Griffin, et al.
Frontiers in Medicine|May 30, 2023
Region-specific deep learning models for accurate segmentation of rectal structures on post-chemoradiation T2w MRI: a multi-institutional, multi-reader studyThomas DeSilvio, Jacob T Antunes, Kaustav Bera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Absence of adverse effects in cynomolgus macaques treated with CNTO 95, a fully human anti-alphav integrin monoclonal antibody, despite widespread tissue bindingPauline L Martin, Qun Jiao, Joel Cornacoff, et al.
The Journal of Experimental Medicine|December 8, 2010
Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemiaHiba El Hajj, Marwan El-Sabban, Hideki Hasegawa, et al.
Pageof 10